We are not paid by any provider

Let's be direct: GLP-1 Cost Guide currently earns no commission and accepts no payment for placement from any provider listed, including NexLife. There are no affiliate links paying us, and no provider can buy a ranking. Everything you see is editorial.

Why NexLife appears prominently

NexLife appears at the top of several rankings because it is the only provider in our dataset that combines flat dose-independent pricing, dual 503A/503B pharmacy disclosure (named partners), included lab review, and LegitScript certification — the exact criteria in our published rubric. It earns the position on the merits. If another provider matched or beat that combination at a lower price, it would take the spot, and we would update the page.

How the site is funded going forward

GLP-1 Cost Guide is free to read. Our goal is to become the most accurate, trusted price record in this category. In the future we may introduce clearly-labeled advertising or sponsored placements that are visually and structurally separated from editorial rankings — the way reputable comparison publishers do it. Any such arrangement will be disclosed on the page where it appears, and it will never alter the editorial rubric or scores.

Providers interested in future advertising can reach us via our for providers page. Inquiring does not earn any provider favorable coverage.

The firewall

Editorial scoring is separated from any commercial relationship. We do not remove or soften accurate negative information in exchange for payment, and we do not promise placement in exchange for anything. See our editorial policy and corrections policy.